Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

Next Generation Sequencing of OVA-treated MutuDC Transcriptome

ABSTRACT: Next Generation Sequencing of OVA-treated MutuDC Transcriptome

PROVIDER: PRJNA1214793 | ENA |

REPOSITORIES: ENA

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
	SRR32104408_1.fastq.gz	Fastqsanger.gz
	SRR32104408_2.fastq.gz	Fastqsanger.gz

Items per page:

1 - 2 of 2

Similar Datasets

Next Generation Sequencing of OVA-treated MutuDC Transcriptome

Project description:The goal of this study is to get the profile of the OVA-treated MutuDC transcriptome. Based on the dada of transcriptome, we processed our sgRNA sequencing data of genome-wide CRISPR/Cas9 screening. Briefly, after we have obtained the enriched gene list from our sgRNA sequencing, we excluded the genes undetected in OVA-treated MutuDC transcriptome to further refine our screening gene list.

2025-01-28 | GSE287836 | GEO

Next Generation Sequencing of splenic- and CNS-infiltrating OT-1 cells in ODC-OVA mice upon LCMV-OVA and Lm-OVA infection

Project description:Purpose: Next-generation sequencing (NGS) has revolutionized systems-based analysis of cellular pathways. The goal of this study is to compare the transcriptome of OT-1 cells during priming (3 days after infection) and during effector phase ( 7 days after infection) in ODC-OVA mice after LCMV-OVA and Lm-OVA infection

2018-05-17 | GSE93805 | GEO

Next Generation Sequencing of CNS-infiltrating Tox-sufficient and -deficient OT-1 cells in ODC-OVA mice 7 days after LCMV-OVA infection

Project description:Purpose: Next-generation sequencing (NGS) has revolutionized systems-based analysis of cellular pathways. The goal of this study is to compare the transcriptome of CNS-infiltrating OT-1 WT and Tox-deficient cells during effector phase (7 days after infection with LCMV-OVA)

2018-05-17 | GSE93804 | GEO

Single-cell level gene expression profiles of immune cells within B16F10-OVA tumours treated with PBS or UDSP-Hep

Project description:Activation of the Alpha kinase 1 (ALPK1) is a promising strategy to be developed as a next-generation cancer immunotherapy. We used single cell RNA sequencing (scRNA-seq) to analyze the ALPK1 activation-triggered antitumour immune responses within the tumour microenvironment of B16F10-OVA tumours treated with PBS or UDSP-Hep.

2024-08-28 | GSE275540 | GEO

Next Generation Sequencing Analysis of mouse tumors treated with rMVA

Project description:Next Generation Sequencing Analysis of mouse tumors treated with rMVA

| PRJNA779078 | ENA

Next Generation Sequencing Analysis of control and siSRSF1 treated RKO cell Transcriptomes

Project description:We treated the RKO cells with siSRSF1 or control siRNA for 48 hours. Then we extracted the RNAs and performed the next generation sequencing. By comparing sequcing data from siSRSF1 and contron siRNA treated samples, we profiled the gene expression regulated by siRNA.

2018-05-01 | GSE98508 | GEO

Next Generation Sequencing Analysis of control and siCHERP treated RKO cell Transcriptomes

Project description:We treated the RKO cells with siCHERP or control siRNA for 72 hours. Then we extracted the RNAs and performed the next generation sequencing. By comparing sequcing data from siCHERP and contron siRNA treated samples, we profiled the gene expression regulated by siRNA.

2019-06-01 | GSE115323 | GEO

Diagnosis of Lynch Syndrome Based on Next-generation Sequencing in Colorectal Cancer

Project description:The purpose of this study is to determine the proportion of patients diagnosed with Lynch syndrome in colorectal cancer patients with the loss of staining by immunohistochemistry (IHC) of any of the mismatch repair (MMR) proteins. Besides, this study aims to test the specificity and the sensitivity of detecting microsatellite instability (MSI) by next-generation sequencing, and to find out the consistency between IHC and MSI in colorectal cancer patients in China. In addition, researchers want to analyze the clinical characteristics and germline mutation of Lynch syndrome in Chinese population.

| 2236244 | ecrin-mdr-crc

Next Generation Sequencing Analysis of control and siSRSF2 treated RKO cells Transcriptomes

Project description:We treated the RKO cells with siSRSF2 or control siRNA for 48 hours.Then, we extracted RNAs and performed next generation sequencing. By comparing sequencing data from control and siSRSF2 samples, we profiled the alternative splicing events and gene expression regulated by SRSF2 in CRC.

2023-06-02 | GSE200272 | GEO

Next Generation Sequencing Analysis of control and siHNRNPM treated RKO cells Transcriptomes

Project description:We treated the RKO cells with siHNRNPM or control siRNA for 48 hours.Then, we extracted RNAs and performed next generation sequencing. By comparing sequencing data from control and siHNRNPM samples, we profiled the alternative splicing events and gene expression regulated by HNRNPM in CRC.

2025-10-20 | GSE300639 | GEO

OmicsDI is part of the ELIXIR infrastructure

OmicsDI is an Elixir interoperability service. Learn more ›

Tweets

OmicsDI Databases

PRIDE
PeptideAtlas
MassIVE
JPOST Repository
Physiome Model Repository

EGA
EVA
ENA
LINCS
PAXDB
Cell Collective

MetaboLights
Metabolomics Workbench
MetabolomeExpress
GNPS
BioModels
FAIRDOMHub

ArrayExpress
dbGaP
ExpressionAtlas
GEO
NODE

Information

Databases
Help
API
Contact us
Code on GitHub
Terms of use
Submit Data